首页> 外国专利> Oral anti-pertussis vaccine - contg. live Bordetella EM 1964 bacteria

Oral anti-pertussis vaccine - contg. live Bordetella EM 1964 bacteria

机译:口服抗百日咳疫苗-续活的博德特氏菌EM 1964细菌

摘要

An anti-pertussis vaccine comprises living bacteria of Bordetella strain EM 1964 in a pharmacologically acceptable support. Less side-effects are encountered than when using vaccines contg. killed Bordetella pertussis bacteria. The bacterial strain is registered at the state Institute for the Control of Medicines, Sofia, Bulgaria under number 321. The vaccine contains 3000,000 to 3,000,000,000 microorganisms per ml, the diluent pref. being physiological saline. It is obtd. by culturing EM 1964 for 48 hours at 37 deg.C in Borget - Genou medium and diluting with saline. It is pref. given orally in two equal doses.
机译:抗百日咳疫苗在药理学上可接受的载体中包含博德特氏菌菌株EM 1964的活细菌。与使用续疫苗相比,副作用较小。杀死百日咳博德特氏菌。该细菌菌株已在保加利亚索非亚州国家药物控制研究所注册,编号为321。疫苗每毫升包含3000,000至3,000,000,000微生物,稀释剂优选。是生理盐水。太过分了。通过在Borget-Genou培养基中于37℃下培养EM 1964达48小时,并用盐水稀释。好。两次等剂量口服。

著录项

  • 公开/公告号NL8103842A

    专利类型

  • 公开/公告日1983-03-16

    原文格式PDF

  • 申请/专利权人 DSO PHARMACHIM TE SOFIA.;

    申请/专利号NL19810003842

  • 发明设计人

    申请日1981-08-17

  • 分类号A61K39/10;

  • 国家 NL

  • 入库时间 2022-08-22 11:06:18

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号